-Targeted Neoadjuvant Therapy Enables Curative Surgery in an Ultra-Elderly Patient With Recurrent Colon Cancer Harboring a CCDC6-RET Fusion.
APA
Jin T, Cricri M, et al. (2026). -Targeted Neoadjuvant Therapy Enables Curative Surgery in an Ultra-Elderly Patient With Recurrent Colon Cancer Harboring a CCDC6-RET Fusion.. JCO precision oncology, 10(4), e2501112. https://doi.org/10.1200/PO-25-01112
MLA
Jin T, et al.. "-Targeted Neoadjuvant Therapy Enables Curative Surgery in an Ultra-Elderly Patient With Recurrent Colon Cancer Harboring a CCDC6-RET Fusion.." JCO precision oncology, vol. 10, no. 4, 2026, pp. e2501112.
PMID
42024841
같은 제1저자의 인용 많은 논문 (5)
- PTPN22 Dephosphorylates CBL to Inhibit PD-L1 Ubiquitination and Drive Immunosuppression in Renal Cell Carcinoma.
- Asymptomatic Lung Adenocarcinoma With Cardiac Metastasis at Initial Diagnosis: A Case Report.
- BUB1/KIF14 complex promotes anaplastic thyroid carcinoma progression by inducing chromosome instability.
- Identification of iron metabolism-related genes as prognostic indicators for papillary thyroid carcinoma: a retrospective study.
- The expression of two immunosuppressive SIGLEC family molecules in papillary thyroid cancer and their effect on prognosis.